Sana Biotechnology Advances In Vivo CAR T Platform
SEATTLE, May 12, 2026 Sana Biotechnology announced new preclinical findings at the 2026 American Society of Gene & Cell...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
SEATTLE, May 12, 2026 Sana Biotechnology announced new preclinical findings at the 2026 American Society of Gene & Cell...
CAMBRIDGE, Mass., April 27, 2026 Sail Biomedicines announced it will present new preclinical data supporting its In Vivo eRNAâ„¢...
